Cargando…
Anticholinergic action is rarely a good thing
The evidence for the risks associated with anticholinergic agents has grown considerably in the last two decades. Not only are they associated with causing peripheral side effects such as dry mouth, blurred vision and constipation, but they can also cause central effects such as cognitive impairment...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493059/ https://www.ncbi.nlm.nih.gov/pubmed/37701892 http://dx.doi.org/10.1177/20451253231195264 |
_version_ | 1785104392570011648 |
---|---|
author | Bishara, Delia |
author_facet | Bishara, Delia |
author_sort | Bishara, Delia |
collection | PubMed |
description | The evidence for the risks associated with anticholinergic agents has grown considerably in the last two decades. Not only are they associated with causing peripheral side effects such as dry mouth, blurred vision and constipation, but they can also cause central effects such as cognitive impairment; and more recently, they have consistently been linked with an increased risk of dementia and death in older people. This paper reviews the evidence for the associations of anticholinergic agents and the risk of dementia and increased mortality in dementia. |
format | Online Article Text |
id | pubmed-10493059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-104930592023-09-11 Anticholinergic action is rarely a good thing Bishara, Delia Ther Adv Psychopharmacol Anticholinergic Effects–Friend or Foe? The evidence for the risks associated with anticholinergic agents has grown considerably in the last two decades. Not only are they associated with causing peripheral side effects such as dry mouth, blurred vision and constipation, but they can also cause central effects such as cognitive impairment; and more recently, they have consistently been linked with an increased risk of dementia and death in older people. This paper reviews the evidence for the associations of anticholinergic agents and the risk of dementia and increased mortality in dementia. SAGE Publications 2023-09-08 /pmc/articles/PMC10493059/ /pubmed/37701892 http://dx.doi.org/10.1177/20451253231195264 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Anticholinergic Effects–Friend or Foe? Bishara, Delia Anticholinergic action is rarely a good thing |
title | Anticholinergic action is rarely a good thing |
title_full | Anticholinergic action is rarely a good thing |
title_fullStr | Anticholinergic action is rarely a good thing |
title_full_unstemmed | Anticholinergic action is rarely a good thing |
title_short | Anticholinergic action is rarely a good thing |
title_sort | anticholinergic action is rarely a good thing |
topic | Anticholinergic Effects–Friend or Foe? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493059/ https://www.ncbi.nlm.nih.gov/pubmed/37701892 http://dx.doi.org/10.1177/20451253231195264 |
work_keys_str_mv | AT bisharadelia anticholinergicactionisrarelyagoodthing |